Integrated Approaches to Vaccine Safety Surveillance: Principles, Challenges, and Innovations
Clicks: 3
ID: 309134
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.6
/100
3 views
2 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #145 of 153 articles by views in International Journal of Pharmaceutical Drug Design (IJPDD)
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 153 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Vaccine safety surveillance plays a pivotal role in ensuring public confidence and maintaining the integrity of immunization programs worldwide. With the rapid development and deployment of vaccines, particularly during global health emergencies, traditional surveillance methods alone are insufficient to address emerging challenges in detecting, evaluating, and managing adverse events following immunization (AEFI). This paper explores integrated approaches to vaccine safety surveillance, highlighting the principles that govern effective monitoring, the limitations of conventional systems, and the need for innovative strategies. It emphasizes the integration of epidemiological studies, pharmacovigilance systems, big data analytics, real-world evidence, artificial intelligence, and digital health tools to enhance early signal detection, causality assessment, and risk communication. Key challenges such as underreporting, data harmonization, ethical considerations, and public trust are critically analyzed. Furthermore, the paper discusses recent innovations including blockchain-enabled data security, machine learning algorithms for predictive modeling, and global collaborative platforms that strengthen vaccine safety monitoring. By adopting a multidimensional and technology-driven approach, stakeholders can build resilient surveillance systems that not only safeguard public health but also foster transparency, trust, and long-term sustainability of immunization programs.
| Reference Key |
imported_1761926372_6904dce408c7f
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Harshada V. Wagh, Girase Prashant D, Jagdeo Chandradeep B, Mahajan Ghanshyam S, Patil Jayesh H, Patil Pratiksha S, Pimple Fuaansha D |
| Journal | International Journal of Pharmaceutical Drug Design (IJPDD) |
| Year | 2025 |
| DOI |
10.62896/ijpdd.2.8.03
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.